Evidence map›Paper›PMID 27133410›Full record

ArticleThe American journal of psychiatry2016

Comment on Analyses and Conclusions of "Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study".

Raj Narendran, W Gordon Frankle

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The American journal of psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Imaging Histamine H3 Receptors with Positron Emission Tomography.Current topics in behavioral neurosciences · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  7. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  8. Article
  9. Sifting through the surfeit of neuroinflammation tracers.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Review
  10. Article
  11. Article
  12. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  13. Article
  14. Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk.International journal of molecular sciences · 2017
    Review
  15. Review
  16. Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Raj NarendranFrom the Department of Psychiatry, University of Pittsburgh Medical Center; and the Department of Psychiatry and Radiology, University of Pittsburgh.
W Gordon FrankleFrom the Department of Psychiatry, University of Pittsburgh Medical Center; and the Department of Psychiatry and Radiology, University of Pittsburgh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Psychotic DisordersSchizophreniaHumansNeuroimagingPositron-Emission Tomography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.